Diagnostic Radioisotopes Global Market Report 2025
상품코드:1825703
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
진단용 방사성 동위원소 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.1%로 성장할 전망이며, 86억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 새로운 방사성 동위원소 제조법, 임상 용도 확대, 환자 중심의 케어 및 안전성, 포인트 오브 케어 화상 진단, 환경의 지속가능성 및 그린 케미스트리에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 하이브리드 이미징 기술, 테라노스틱스, 분자 이미징 기술, 사이클로트론 또는 발전기의 사용, 안전 및 방사선 보호 등이 있습니다.
향후 5년간의 성장률 9.1%라고 하는 예측은 이 시장 전회 예측으로부터 0.6%라고 하는 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세의 부과로 인해 캐나다와 벨기에에서 수입되는 테크네튬 99m 및 기타 중요한 방사성 동위원소의 비용이 상승하고 영상 진단의 정확성이 저하되며 종양학 및 심장병 검사 비용이 증가할 수 있으므로 미국 핵의학이 혼란스러울 수 있습니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
암 부담 증가가 진단용 방사성 동위원소 시장의 확대를 견인할 것으로 예측됩니다. 암은 주변 조직을 손상시키는 비정상적인 세포의 무질서한 분열을 특징으로 하는 질병입니다. 암 유병률 증가는 흡연, 비만, 운동 부족 등의 라이프스타일의 선택, 발암물질에 대한 노출, 유전적 요인, 환경의 영향 등 다양한 요인에 기인하고 있습니다. 방사성 동위원소는 정확한 진단을 제공하고, 적당한 치료를 가능하게 하며, 암의 진행이나 치료에 대한 반응을 효과적으로 모니터링하는 것을 용이하게 함으로써, 암 관리에 있어서 중요한 역할을 하고 있습니다. 예를 들어 2024년 5월 미국을 거점으로 암 연구 및 훈련에 중점을 둔 정부기관인 국립 암 연구소는 2040년까지 세계 연간 신규 암 환자 수는 2,990만 명에 달할 전망이며, 암과 관련된 사망자 수는 1,530만 명에 달할 것으로 예측했습니다. 그 결과, 암의 부담 증가가 진단용 방사성 동위원소 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 진단용 방사성 동위원소 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 진단용 방사성 동위원소 시장 : 성장률 분석
세계의 진단용 방사성 동위원소 시장 실적 : 규모 및 성장(2019-2024년)
세계의 진단용 방사성 동위원소 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 진단용 방사성 동위원소 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 진단용 방사성 동위원소 시장 : 방사성 동위원소별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
테크네튬 99m
탈륨 201
갈륨 67
요오드 123
플루오로데옥시글루코스(FDG)
루비듐 82
기타 방사성 동위 원소
세계의 진단용 방사성 동위원소 시장 : 화상 진단법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
단일 광자 방출 컴퓨터 단층 촬영(SPECT)
양전자 방출 단층 촬영(PET)
베타선 방사체
세계의 진단용 방사성 동위원소 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양학
심장병학
기타 용도
세계 진단용 방사성 동위원소 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
진단센터
학술연구기관
기타 최종 사용자
세계의 진단용 방사성 동위원소 시장 : 테크네튬 99m 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
진단 이미지
심장 이미지
종양 영상 진단
뼈 스캔
신장 스캔
세계의 진단용 방사성 동위원소 시장 : 탈륨 201 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
심장 이미지
심근 관류 영상
스트레스 테스트
세계의 진단용 방사성 동위원소 시장 : 갈륨 67 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
종양 영상 진단(림프종, 종양)
염증성 질환의 화상 진단
감염 화상 진단
세계의 진단용 방사성 동위원소 시장 : 요오드 123 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
갑상선 영상 검사
신경학적 화상 검사(파킨슨병)
심장 이미지
세계 진단용 방사성 동위원소 시장 : 플루오로데옥시글루코스(FDG) 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
양전자 방출 단층 촬영(PET) 이미지
암 진단과 병기 분류
신경 화상
심장 이미지
세계의 진단용 방사성 동위원소 시장 : 루비듐 82 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
심장 PET 이미지
심근 관류 영상
관상 동맥 질환의 진단
세계의 진단용 방사성 동위원소 시장 : 기타 방사성 동위원소 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
스트론튬 89(골통 완화)
요오드 131(갑상선암의 치료)
사마륨 153(골통 완화)
이트륨 90(암 치료)
제7장 지역별 및 국가별 분석
세계의 진단용 방사성 동위원소 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 진단용 방사성 동위원소 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
진단용 방사성 동위원소 시장 : 경쟁 구도
진단용 방사성 동위원소 시장 : 기업 프로파일
Cardinal Health Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sumitomo Heavy Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
BWX Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Lantheus Holdings : 개요, 제품 및 서비스, 전략 및 재무 분석
Curium Pharma : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Clarity Pharmaceuticals
Bracco Diagnostic Inc.
Ion Beam Applications SA
Nordion Inc.
Eckert & Ziegler AG
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
Global Medical Solutions Ltd.
Isotopia Molecular Imaging Ltd.
Cyclopharm Limited
Trasis NV
Orano Med LLC
ARTMS Inc.
Radiomedix Inc.
Coqu RadioPharmaceuticals Corp.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
진단용 방사성 동위원소 시장(2029년) : 새로운 기회를 제공하는 국가
진단용 방사성 동위원소 시장(2029년) : 새로운 기회를 제공하는 부문
진단용 방사성 동위원소 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.
The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diagnostic radioisotopes market size has grown strongly in recent years. It will grow from $5.54 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.
The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.
The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. nuclear medicine by raising costs for technetium-99m and other critical radioisotopes imported from Canada and Belgium, potentially compromising imaging accuracy and increasing oncology and cardiology scan costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing burden of cancer is expected to drive the expansion of the diagnostic radioisotopes market. Cancer is a disease characterized by the uncontrolled division of abnormal cells that damage surrounding tissue. The increasing prevalence of cancer is attributed to various factors, including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic factors, and environmental influences. Radioisotopes play a crucial role in cancer management by providing accurate diagnosis, enabling targeted treatments, and facilitating effective monitoring of cancer progression or response to therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that by 2040, the global number of new cancer cases per year will reach 29.9 million, with 15.3 million cancer-related deaths. As a result, the rising burden of cancer is driving the growth of the diagnostic radioisotopes market.
Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.
In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.
Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC
North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diagnostic Radioisotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
3) By Application: Oncology; Cardiology; Other Applications
4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users
Subsegments:
1) By Technetium-99m: Diagnostic Imaging; Cardiac Imaging; Oncology Imaging; Bone Scans; Renal Scans
2) By Thallium-201: Cardiac Imaging; Myocardial Perfusion Imaging; Stress Tests
3. Diagnostic Radioisotopes market Trends And Strategies
4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework
5.1. Global Diagnostic Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Diagnostic Radioisotopes market Growth Rate Analysis
5.4. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Diagnostic Radioisotopes Total Addressable Market (TAM)
6. Diagnostic Radioisotopes market Segmentation
6.1. Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Technetium-99m
Thallium-201
Gallium-67
Iodine-123
FluoroDeoxyGlucose (FDG)
Rubidium-82
Other Radioisotopes
6.2. Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Beta Emitters
6.3. Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiology
Other Applications
6.4. Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Diagnostic Centers
Academic And Research Institutes
Other End Users
6.5. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Imaging
Cardiac Imaging
Oncology Imaging
Bone Scans
Renal Scans
6.6. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac Imaging
Myocardial Perfusion Imaging
Stress Tests
6.7. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology Imaging (Lymphoma, Tumors)
Inflammatory Disease Imaging
Infection Imaging
6.8. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thyroid Imaging
Neurological Imaging (Parkinson's Disease)
Cardiac Imaging
6.9. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Positron Emission Tomography (PET) Imaging
Cancer Diagnosis And Staging
Neurological Imaging
Cardiac Imaging
6.10. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiac PET Imaging
Myocardial Perfusion Imaging
Coronary Artery Disease Diagnosis
6.11. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Strontium-89 (Bone Pain Palliation)
Iodine-131 (Thyroid Cancer Treatment)
Samarium-153 (Bone Pain Palliation)
Yttrium-90 (Cancer Treatment)
7. Diagnostic Radioisotopes market Regional And Country Analysis
7.1. Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
